Section 2.19. Additions, deletions and transfers to statutory schedules.

 

(1)   Paragraph (b) of s. 161.20 (4), Stats. , is created to read:

(b) Not more than 25 milligrams per dosage unit of pentazocine with one or more active, non-narcotic ingredients in recognized therapeutic amounts.

(2)   Paragraph (b) of s. 161.18 (4), Stats. , is repealed.

(3)   Paragraph (km) of s. 161.20 (2), Stats. , is renumbered to read:

(mg) Prazepam;

(4)   Paragraph (hg) of s. 161.20 (2), Stats. , is created to read:

(hg) Midazolam;

(5)   Paragraph (mm) of s. 161.20 (2), Stats. , is created to read:

(mm) Quazepam;

(6)   Paragraph (km) of s. 161.18 (3), Stats. , is created to read:

(km) Tiletamine and Zolazepam or any salt thereof;

(7)   Paragraph (a) of s. 161.16 (3), Stats. , is renumbered to read:

(am) Alphaprodine;

(8)   Paragraph (a) of s. 161.16 (3), Stats. , is created to read:

(a) Alfentanil;

(9)   Paragraph (rg) of s. 161.14 (2), Stats. , is created to read:

(rg) MPPP 1-methyl-4-phenyl-4-propionoxypiperidine);

(10)   Paragraph (vg) of s. 161.14 (2), Stats. , is created to read:

(vg) (PEPAP) 1-(2-phenethyl)-4-phenyl-4-acetoxypiperidine;

(11)   Paragraph (b) of s. 161.16 (10), Stats. , is created to read:

(b) Nabilone (another name for nabilone: (+)-trans-3- (1,1-dimethylheptyl)-6, 6a, 7, 8, 10, 10a-hexahydro-1- hydroxy-6, 6-dimethyl-9H-dibenzo [b,d] pyran-9-one).

(12)   Subsection (2) of s. 161.14, Stats. , is amended to read:

(2) Opiates. Unless specifically excepted under federal regulations or unless listed in another schedule, any of the following opiates, or their isomers, esters, ethers, salts, salts of isomers, esters of ethers, if isomers, esters, ethers, salts or salts of isomers exist within the specified chemical designation (for purposes of par. (tg ) only, the term isomer includes the optical and geometric isomers):

(13)   Paragraph (a) of s. 161.14 (2), Stats. , is renumbered to read:

(ag) Acetylmethadol;

(14)   Paragraph (a) of s. 161.14 (2), Stats. , is created to read:

(a) Acetyl-alpha-methylfentanyl (N-(1-(1-methyl-2-phenethyl)-4-piperidinyl]-N-phenylacetamide);

(15)   Paragraph (cg) of s. 161.14 (2), Stats. , is created to read:

(cg) Alpha-methylthiofentanyl (N-[1-methyl-2-(2-thienyl)ethyl-4-piperidinyl]-N-phenylpropanamide);

(16)   Paragraph (dg) of s. 161.14 (2), Stats. , is created to read:

(dg) Beta-hydroxyfentanyl (N-[1-(2-hydroxy-2-phenethyl) -4-piperidinyl]-N-phenylpropanamide) ;

(17)    Paragraph (rj) of s. 161.14 (2), Stats. , is created to read:

(rj) 3-methylthiofentanyl (N-[3-methyl-1-(2-thienyl) ethyl-4-piperidinyl]-N-phenylpropanamide);

(18)   Paragraph (tg) of s. 161.14 (2), Stats ., is created to read:

(tg) Para-fluorofentanyl (N-(4-fluorophenyl)-N-[1- (2-phenethyl)-4-piperidinyl]propanamide);

(19)   Paragraph (xm) of s. 161.14 (2), Stats. , is created to read:

(xm) Thiofentanyl (N-phenyl-N-[1-(2-thienyl)ethyl-4-piperidinyl]propanamide);

Cr. Register, February, 1988, No. 386 , eff. 3-1-88.